T cell mediated hypersensitivity to previously tolerated iodinated contrast media precipitated by introduction of atezolizumab.
J Immunother Cancer
; 9(5)2021 05.
Article
in En
| MEDLINE
| ID: mdl-34049931
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Renal Cell
/
T-Lymphocytes
/
Stevens-Johnson Syndrome
/
Contrast Media
/
Diatrizoate
/
Antibodies, Monoclonal, Humanized
/
Immune Checkpoint Inhibitors
/
Kidney Neoplasms
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
/
Male
Language:
En
Journal:
J Immunother Cancer
Year:
2021
Document type:
Article
Affiliation country:
United kingdom
Country of publication:
United kingdom